Status:
COMPLETED
Effectiveness in Limiting the Need to Elevate the Maxillary Sinus
Lead Sponsor:
International Piezosurgery Academy
Conditions:
Alveolar Bone Loss
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The aim of the present study is to evaluate the effectiveness of different alveolar preservation procedures performed at the time of extraction of the first or second upper molar in avoiding a maxilla...
Detailed Description
Bone resorption and contraction of bone volumes are physiologically occurring after the extraction of any dental element. This reabsorption of the alveolar process results in a reduction in the size o...
Eligibility Criteria
Inclusion
- indication for extraction of the first or second upper molar, based on a thorough diagnosis and treatment plan;
- "three-rooted" anatomy of the first or second upper molar to be extracted so that it can have an inter-radicular septum that allows a precise measurement of the height of the bone ridge from the septum itself and from the walls of the 3 alveoli to the floor of the maxillary sinus;
- Extraction of intercalate molar or last arch element;
Exclusion
- Anatomy of the molar with unique root or fused roots
- contextual extraction of the molar and one or more contiguous elements
- apical lesions with a diameter of\> 3 mm or cystic lesions with respect to the element to be extracted
- root fracture which has produced resorption or bone fenestration
- 1\) acute myocardial infarction in the last six months; 2) uncontrolled clotting disorders; 3) uncontrolled diabetes (HBA1c\> 7.5%); 4) radiotherapy in the head / neck district for the last 24 months; 5) immunocompromise (eg HIV infection or chemotherapy over the last 3 years); 6) treatment in progress or with bisphosphonates via e.v .; 7) autoimmune diseases in chronic therapy with methotrexate or other immunosuppressive drugs; 8) allergy to bovine collagen; 9) psychological or psychiatric problems; 10) abuse of alcohol or drug use; 11) uncontrolled periodontal disease;
Key Trial Info
Start Date :
October 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03357705
Start Date
October 31 2017
End Date
December 28 2018
Last Update
March 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Piezosurgery Academy
Parma, Italy, 43100